Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Sanson

Showing results (161-170 of 290) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2011
A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951Martin J van den Bent, Lonneke A Gravendeel, Thierry Gorlia, et al.
Plos One|September 19, 2014
DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomideAmandine Etcheverry, Marc Aubry, Ahmed Idbaih, et al.
Scientific Reports|May 14, 2021
Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivorsRobert Terziev, Dimitri Psimaras, Yannick Marie, et al.
Journal of Neuro-Oncology|June 18, 2010
Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytomaFrançois Ducray, Monica Sierra del Rio, Catherine Carpentier, et al.
Cancer Cell International|April 19, 2011
Correction: ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic targetSandra-Nadia Ngwabyt Bikeye, Carole Colin, Yannick Marie, et al.
Cancer Cell International|February 10, 2010
ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic targetSandra-Nadia Ngwabyt Bikeye, Carole Colin, Yannick Marie, et al.
Brain Pathology (Zurich, Switzerland)|September 28, 2019
Ki-67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q-codeleted: a multicenter study from the French POLA networkCelso Pouget, Sébastien Hergalant, Emilie Lardenois, et al.
Molecular Neurobiology|February 3, 2017
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-ChemotherapyFrancesco Pasqualetti, Paola Orlandi, Vittorio Simeon, et al.
Brain Pathology (Zurich, Switzerland)|May 18, 2012
KIAA1549-BRAF fusions and IDH mutations can coexist in diffuse gliomas of adultsManuela Badiali, Vincent Gleize, Sophie Paris, et al.
Cancers|April 3, 2021
An AI-Powered Blood Test to Detect Cancer Using NanoDSFPhilipp O Tsvetkov, Rémi Eyraud, Stéphane Ayache, et al.
Pageof 29

Showing results (161-170 of 290) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2011
A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951Martin J van den Bent, Lonneke A Gravendeel, Thierry Gorlia, et al.
Plos One|September 19, 2014
DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomideAmandine Etcheverry, Marc Aubry, Ahmed Idbaih, et al.
Scientific Reports|May 14, 2021
Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivorsRobert Terziev, Dimitri Psimaras, Yannick Marie, et al.
Journal of Neuro-Oncology|June 18, 2010
Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytomaFrançois Ducray, Monica Sierra del Rio, Catherine Carpentier, et al.
Cancer Cell International|April 19, 2011
Correction: ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic targetSandra-Nadia Ngwabyt Bikeye, Carole Colin, Yannick Marie, et al.
Cancer Cell International|February 10, 2010
ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic targetSandra-Nadia Ngwabyt Bikeye, Carole Colin, Yannick Marie, et al.
Brain Pathology (Zurich, Switzerland)|September 28, 2019
Ki-67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q-codeleted: a multicenter study from the French POLA networkCelso Pouget, Sébastien Hergalant, Emilie Lardenois, et al.
Molecular Neurobiology|February 3, 2017
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-ChemotherapyFrancesco Pasqualetti, Paola Orlandi, Vittorio Simeon, et al.
Brain Pathology (Zurich, Switzerland)|May 18, 2012
KIAA1549-BRAF fusions and IDH mutations can coexist in diffuse gliomas of adultsManuela Badiali, Vincent Gleize, Sophie Paris, et al.
Cancers|April 3, 2021
An AI-Powered Blood Test to Detect Cancer Using NanoDSFPhilipp O Tsvetkov, Rémi Eyraud, Stéphane Ayache, et al.
Pageof 29